$REPH Recro Pharma, Inc. Insider Trading Week 48/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. in week 48/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.61 | 100 | 961 | 2,705,262 | 2.7 M to 2.7 M (0.00 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.55 | 100,000 | 955,000 | 2,705,362 | 2.8 M to 2.7 M (-3.56 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.55 | 50,000 | 477,500 | 2,805,362 | 2.9 M to 2.8 M (-1.75 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.62 | 5,000 | 48,100 | 2,855,362 | 2.9 M to 2.9 M (-0.17 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.69 | 500 | 4,845 | 2,860,362 | 2.9 M to 2.9 M (-0.02 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.63 | 6,322 | 60,881 | 2,860,862 | 2.9 M to 2.9 M (-0.22 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 100 | 971 | 2,867,184 | 2.9 M to 2.9 M (0.00 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 6,381 | 61,960 | 2,867,284 | 2.9 M to 2.9 M (-0.22 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.66 | 3,764 | 36,360 | 2,873,665 | 2.9 M to 2.9 M (-0.13 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 700 | 6,776 | 2,877,429 | 2.9 M to 2.9 M (-0.02 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 2,200 | 21,296 | 2,878,129 | 2.9 M to 2.9 M (-0.08 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.56 | 21,619 | 206,678 | 2,880,329 | 2.9 M to 2.9 M (-0.74 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 1,500 | 14,520 | 2,901,948 | 2.9 M to 2.9 M (-0.05 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 24,430 | 237,215 | 2,903,448 | 2.9 M to 2.9 M (-0.83 %) |